vs
Assertio Holdings, Inc.（ASRT）与Star Holdings（STHO）财务数据对比。点击上方公司名可切换其他公司
Star Holdings的季度营收约是Assertio Holdings, Inc.的1.9倍（$25.4M vs $13.5M），Star Holdings同比增速更快（-22.6% vs -57.9%），过去两年Star Holdings的营收复合增速更高（-0.2% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
蓝星有限公司是一家印度跨国家电企业，总部位于孟买，主营空调、商用制冷以及机电工程业务，是印度本土市场规模第二大的空调领域本土企业。
ASRT vs STHO — 直观对比
营收规模更大
STHO
是对方的1.9倍
$13.5M
营收增速更快
STHO
高出35.3%
-57.9%
两年增速更快
STHO
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $25.4M |
| 净利润 | — | $-19.1M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | -91.7% |
| 净利率 | — | -75.5% |
| 营收同比 | -57.9% | -22.6% |
| 净利润同比 | — | 81.3% |
| 每股收益（稀释后） | $-4.54 | $-1.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTSTHO
| Q4 25 | $13.5M | $25.4M | ||
| Q3 25 | $49.5M | $28.1M | ||
| Q2 25 | $29.2M | $42.1M | ||
| Q1 25 | $26.5M | $14.6M | ||
| Q4 24 | $32.2M | $32.8M | ||
| Q3 24 | $29.2M | $24.6M | ||
| Q2 24 | $31.1M | $30.6M | ||
| Q1 24 | $32.4M | $25.4M |
净利润ASRTSTHO
| Q4 25 | — | $-19.1M | ||
| Q3 25 | $11.4M | $1.8M | ||
| Q2 25 | $-16.4M | $-39.3M | ||
| Q1 25 | $-13.5M | $-7.6M | ||
| Q4 24 | — | $-102.6M | ||
| Q3 24 | $-2.9M | $91.9M | ||
| Q2 24 | $-3.7M | $-27.1M | ||
| Q1 24 | $-4.5M | $-49.0M |
营业利润率ASRTSTHO
| Q4 25 | -86.7% | -91.7% | ||
| Q3 25 | 23.2% | 1.0% | ||
| Q2 25 | -27.5% | -94.5% | ||
| Q1 25 | -50.0% | -55.0% | ||
| Q4 24 | -41.9% | -314.1% | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -11.6% | -91.5% | ||
| Q1 24 | -13.4% | -192.6% |
净利率ASRTSTHO
| Q4 25 | — | -75.5% | ||
| Q3 25 | 23.1% | 6.4% | ||
| Q2 25 | -56.0% | -93.5% | ||
| Q1 25 | -51.1% | -52.0% | ||
| Q4 24 | — | -313.1% | ||
| Q3 24 | -10.0% | 374.3% | ||
| Q2 24 | -11.8% | -88.8% | ||
| Q1 24 | -13.9% | -192.6% |
每股收益（稀释后）ASRTSTHO
| Q4 25 | $-4.54 | $-1.52 | ||
| Q3 25 | $0.11 | $0.14 | ||
| Q2 25 | $-0.17 | $-2.95 | ||
| Q1 25 | $-0.14 | $-0.57 | ||
| Q4 24 | $-3.28 | $-7.69 | ||
| Q3 24 | $-0.03 | $6.90 | ||
| Q2 24 | $-0.04 | $-2.04 | ||
| Q1 24 | $-0.05 | $-3.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $50.1M |
| 总债务越低越好 | — | $268.7M |
| 股东权益账面价值 | $94.0M | $251.8M |
| 总资产 | $267.0M | $570.2M |
| 负债/权益比越低杠杆越低 | — | 1.07× |
8季度趋势，按日历期对齐
现金及短期投资ASRTSTHO
| Q4 25 | $63.4M | $50.1M | ||
| Q3 25 | $93.4M | $40.6M | ||
| Q2 25 | $98.2M | $44.2M | ||
| Q1 25 | $87.3M | $30.3M | ||
| Q4 24 | $100.1M | $35.0M | ||
| Q3 24 | $88.6M | $45.0M | ||
| Q2 24 | $88.4M | $48.3M | ||
| Q1 24 | $80.7M | $45.7M |
总债务ASRTSTHO
| Q4 25 | — | $268.7M | ||
| Q3 25 | — | $259.3M | ||
| Q2 25 | — | $245.4M | ||
| Q1 25 | — | $231.5M | ||
| Q4 24 | — | $217.3M | ||
| Q3 24 | — | $201.2M | ||
| Q2 24 | — | $197.2M | ||
| Q1 24 | $38.6M | $195.0M |
股东权益ASRTSTHO
| Q4 25 | $94.0M | $251.8M | ||
| Q3 25 | $105.8M | $275.4M | ||
| Q2 25 | $93.3M | $276.1M | ||
| Q1 25 | $108.5M | $316.1M | ||
| Q4 24 | $121.1M | $324.3M | ||
| Q3 24 | $130.5M | $427.5M | ||
| Q2 24 | $132.2M | $335.3M | ||
| Q1 24 | $134.5M | $362.4M |
总资产ASRTSTHO
| Q4 25 | $267.0M | $570.2M | ||
| Q3 25 | $319.8M | $595.9M | ||
| Q2 25 | $273.8M | $589.9M | ||
| Q1 25 | $286.4M | $618.2M | ||
| Q4 24 | $284.7M | $608.7M | ||
| Q3 24 | $276.0M | $696.5M | ||
| Q2 24 | $279.4M | $601.0M | ||
| Q1 24 | $282.0M | $622.9M |
负债/权益比ASRTSTHO
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 0.94× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.59× | ||
| Q1 24 | 0.29× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-11.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTSTHO
| Q4 25 | $-30.0M | $-11.7M | ||
| Q3 25 | $-4.8M | $5.3M | ||
| Q2 25 | $19.1M | $-2.6M | ||
| Q1 25 | $-12.5M | $-6.3M | ||
| Q4 24 | $11.5M | $-31.3M | ||
| Q3 24 | $-35.0K | $-3.8M | ||
| Q2 24 | $7.4M | $-6.4M | ||
| Q1 24 | $7.5M | $-14.2M |
资本支出强度ASRTSTHO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTSTHO
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | 2.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
STHO
| Land Development | $13.0M | 51% |
| Other Income Revenue | $9.3M | 37% |
| Operating Lease Income | $2.0M | 8% |
| Other | $1.2M | 5% |
